Latest Atlas Venture Life Science Advisors, LLC Stock Portfolio
$1.08Billion
Equity Portfolio Value
Last Reported on: 06 May, 2024
About Atlas Venture Life Science Advisors, LLC and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Atlas Venture Life Science Advisors, LLC reported an equity portfolio of $1.1 Billions as of 31 Mar, 2024.
The top stock holdings of Atlas Venture Life Science Advisors, LLC are DYN, KYMR, . The fund has invested 21% of it's portfolio in DYNE THERAPEUTICS, INC. and 20% of portfolio in KYMERA THERAPEUTICS, INC.
The fund managers got completely rid off AKERO THERAPEUTICS, INC. (AKRO) stocks. They significantly reduced their stock positions in XILIO THERAPEUTICS, INC. (XLO), SPERO THERAPEUTICS, INC. (SPRO) and DIANTHUS THERAPEUTICS, INC.. Atlas Venture Life Science Advisors, LLC opened new stock positions in Q32 BIO, INC..
The top stock holdings of Atlas Venture Life Science Advisors, LLC are DYN, KYMR, . The fund has invested 21% of it's portfolio in DYNE THERAPEUTICS, INC. and 20% of portfolio in KYMERA THERAPEUTICS, INC.
The fund managers got completely rid off AKERO THERAPEUTICS, INC. (AKRO) stocks. They significantly reduced their stock positions in XILIO THERAPEUTICS, INC. (XLO), SPERO THERAPEUTICS, INC. (SPRO) and DIANTHUS THERAPEUTICS, INC.. Atlas Venture Life Science Advisors, LLC opened new stock positions in Q32 BIO, INC..
New Buys
| Ticker | $ Bought |
|---|---|
| Q32 BIO, INC. | 35,649,500 |
New stocks bought by Atlas Venture Life Science Advisors, LLC
Additions
Reductions
| Ticker | % Reduced |
|---|---|
| XILIO THERAPEUTICS, INC. | -64.02 |
| SPERO THERAPEUTICS, INC. | -40.04 |
| DIANTHUS THERAPEUTICS, INC. | -21.1 |
| DYNE THERAPEUTICS, INC. | -18.87 |
| DAY ONE BIOPHARMACEUTICALS, INC. | -15.48 |
| DISC MEDICINE, INC. | -10.49 |
| KYMERA THERAPEUTICS, INC. | -8.21 |
Atlas Venture Life Science Advisors, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| AKERO THERAPEUTICS, INC. | -8,388,510 |
Atlas Venture Life Science Advisors, LLC got rid off the above stocks
Current Stock Holdings of Atlas Venture Life Science Advisors, LLC
Last Reported on: 06 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| AKRO | AKERO THERAPEUTICS, INC. | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| AVRO | AVROBIO, INC. | 0.54 | 4,541,380 | 5,812,970 | UNCHANGED | 0.00 | |
| AVTE | AEROVATE THERAPEUTICS, INC. | 5.57 | 2,039,250 | 60,300,600 | UNCHANGED | 0.00 | |
| DAWN | DAY ONE BIOPHARMACEUTICALS, INC. | 9.80 | 6,430,260 | 106,228,000 | REDUCED | -15.48 | |
| DYN | DYNE THERAPEUTICS, INC. | 21.01 | 8,020,140 | 227,692,000 | REDUCED | -18.87 | |
| GBIO | GENERATION BIO, CO. | 3.11 | 8,279,480 | 33,697,500 | UNCHANGED | 0.00 | |
| IKNA | IKENA ONCOLOGY, INC. | 0.66 | 5,018,180 | 7,125,810 | UNCHANGED | 0.00 | |
| KYMR | KYMERA THERAPEUTICS, INC. | 19.95 | 5,377,360 | 216,170,000 | REDUCED | -8.21 | |
| REPL | REPLIMUNE GROUP, INC. | 1.58 | 2,098,300 | 17,143,100 | UNCHANGED | 0.00 | |
| SPRO | SPERO THERAPEUTICS, INC. | 0.10 | 607,613 | 1,045,090 | REDUCED | -40.04 | |
| THRD | THIRD HARMONIC BIO, INC. | 9.50 | 10,907,900 | 102,970,000 | UNCHANGED | 0.00 | |
| VIGL | VIGIL NEUROSCIENCE, INC. | 1.84 | 5,836,870 | 19,903,700 | UNCHANGED | 0.00 | |
| XLO | XILIO THERAPEUTICS, INC. | 0.10 | 992,912 | 1,072,340 | REDUCED | -64.02 | |
| DISC MEDICINE, INC. | 13.14 | 2,287,230 | 142,403,000 | REDUCED | -10.49 | ||
| KORRO BIO, INC. | 9.30 | 1,119,290 | 100,736,000 | UNCHANGED | 0.00 | ||
| Q32 BIO, INC. | 3.29 | 2,092,110 | 35,649,500 | NEW | |||
| DIANTHUS THERAPEUTICS, INC. | 0.52 | 186,979 | 5,609,370 | REDUCED | -21.1 |